Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Long-Term Investments (2021 - 2025)

Korro Bio (KRRO) has disclosed Long-Term Investments for 4 consecutive years, with $10.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Long-Term Investments fell 68.82% year-over-year to $10.0 million, compared with a TTM value of $10.0 million through Sep 2025, down 68.82%, and an annual FY2024 reading of $37.0 million, changed N/A over the prior year.
  • Long-Term Investments was $10.0 million for Q3 2025 at Korro Bio, down from $23.3 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $37.0 million in Q4 2024 and bottomed at $6.6 million in Q2 2021.
  • Average Long-Term Investments over 4 years is $19.5 million, with a median of $17.8 million recorded in 2021.
  • Peak annual rise in Long-Term Investments hit 23.33% in 2025, while the deepest fall reached 68.82% in 2025.
  • Year by year, Long-Term Investments stood at $11.7 million in 2021, then plummeted by 36.77% to $7.4 million in 2022, then skyrocketed by 398.77% to $37.0 million in 2024, then tumbled by 72.91% to $10.0 million in 2025.
  • Business Quant data shows Long-Term Investments for KRRO at $10.0 million in Q3 2025, $23.3 million in Q2 2025, and $24.0 million in Q1 2025.